By Michael Erman NEW YORK (Reuters) – Now that the U.S. government has negotiated prices for some Medicare drugs that will take effect in 2026, Wall Street analysts are betting that a list will appear in 2027 that will include Novo Nordisk’s blockbuster Ozempic for diabetes and will have only a limited impact on major […]
Now that the U.S. government has negotiated prices for some Medicare drugs that will take effect in 2026, Wall Street analysts are betting on a 2027 list that will include Novo Nordisk’s (NVO) diabetes blockbuster Ozempic and have only a limited impact on major pharmaceutical companies. Other possible candidates for 2027 include Pfizer’s (PFE) cancer […]
The Biden administration on Thursday announced an agreement between Medicare and pharmaceutical companies to lower prices on 10 prescription drugs. The government says this will save about $6 billion over the prices Medicare pays for the same drugs this year. The Centers for Medicare & Medicaid Services (CMS) estimates that 8.8 million of the 54 […]
Why hospital prices vary widely even when prices vary by miles A new federal regulation requiring U.S. hospitals to disclose all prices has revealed how much rates vary from hospital to hospital, even if they are only a few miles apart. More than a third of New Jersey’s 79 hospitals received two stars or less […]
